The majority of the patients had well-preserved synthetic function (eg, bilirubin and albumin), fewer than 15% had evidence of portal hypertension, and nearly 80% had early-stage HCC (BCLC-0 or BCLC-A). The gene discussed is ALB; the disease is hepatocellular carcinoma.